V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004063 | 300002847 | 1.62 | 60.3 | Neo-adjuvant (N) | 2014-12-11 | 2014-12-12 | Cisplatin +Fluorouracil (3 wk) | 2 | null | 300017834 | CISPLATIN + FLUOROURACIL |
| 300004065 | 300002849 | null | 63 | Curative (C) | 2015-09-26 | 2015-10-18 | Trial Unspecified | null | null | 300017837 | TRIAL |
| 300004066 | 300002850 | 1.61 | 81.1 | Curative (C) | null | 2016-10-24 | CISPLATIN + FLUOROURACIL | Y | null | 300017844 | CISPLATIN + FLUOROURACIL |
| 300004067 | 300006054 | 1.77 | 105 | Curative (C) | 2017-01-27 | 2017-01-30 | Cetuximab + Radiotherapy Load | N | Y | 300017847 | CETUXIMAB + RT |
| 300004068 | 300006054 | 1.69 | 75 | Palliative (P) | null | 2014-04-27 | Cisplatin +Fluorouracil (3 wk) | null | null | 300017847 | CISPLATIN + FLUOROURACIL |
| 300004069 | 300002851 | null | 104.1 | Neo-adjuvant (N) | 2013-12-25 | 2014-01-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017852 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004070 | 300002852 | 1.6 | 65.8 | Curative (C) | 2018-05-24 | 2018-05-25 | Trial Unspecified | 02 | N | 300017854 | TRIAL |
| 300004071 | 300002853 | null | 106 | Curative (C) | null | 2013-06-28 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300017857 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004072 | 300002854 | 1.68 | 70.8 | 3 | null | 2016-04-15 | CISPLATIN + FLUOROURACIL | null | null | 300017859 | CISPLATIN + FLUOROURACIL |
| 300004073 | 300002854 | 1.77 | 76.9 | Curative (C) | 2015-03-09 | 2015-03-22 | Cisplatin + Docetaxel +Fluorouracil | Y | N | 300017859 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004074 | 300002854 | 1.72 | 95 | Curative (C) | 2013-12-28 | 2014-01-17 | Cetuximab + Radiotherapy Load | N | N | 300017859 | CETUXIMAB + RT |
| 300004076 | 300002856 | 1.8 | 71.1 | Curative (C) | 2017-07-04 | 2017-07-13 | Cetuximab 7 day (Cycle 1) | 02 | null | 300017866 | CETUXIMAB |
| 300004077 | 300002857 | 1.77 | 102.3 | Palliative (P) | 2013-11-11 | 2013-11-11 | Trial Unspecified | 02 | null | 300017867 | TRIAL |
| 300004078 | 300002858 | 1.7 | 124 | Adjuvant (A) | 2017-03-30 | 2017-04-04 | Capecitabine | 02 | N | 300017870 | CAPECITABINE |
| 300004079 | 300002859 | null | 57 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017875 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004080 | 300002860 | 1.63 | 84.6 | Neo-adjuvant (N) | 2013-04-17 | 2013-05-14 | CISPLATIN + FLUOROURACIL | N | null | 300017878 | CISPLATIN + FLUOROURACIL |
| 300004081 | 300002860 | 1.53 | 86.4 | Neo-adjuvant (N) | 2014-04-15 | 2014-04-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 300017878 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004082 | 300002861 | 1.6 | 70 | Palliative (P) | 2013-08-01 | 2013-08-11 | Cetuximab 7 day (Cycle 1) | 2 | null | 300017882 | CETUXIMAB |
| 300004083 | 300002862 | 1.62 | 41.8 | null | null | 2014-05-14 | Trial Unspecified | N | N | 300017885 | TRIAL |
| 300004084 | 300002863 | 1.56 | 43.15 | Curative (C) | 2014-08-05 | 2014-08-27 | Cetuximab 7 day (Cycle 1) | N | Y | 300017886 | CETUXIMAB |
| 300004085 | 300002864 | 1.59 | 73.1 | Curative (C) | 2017-01-17 | 2017-01-18 | CISPLATIN + FLUOROURACIL | null | null | 300017888 | CISPLATIN + FLUOROURACIL |
| 300004086 | 300002865 | 1.72 | 104.1 | Adjuvant (A) | 2017-03-19 | 2017-03-30 | Capecitabine | 02 | null | 300017893 | CAPECITABINE |
| 300004087 | 300002866 | 1.83 | 68.4 | null | 2016-12-05 | 2016-12-30 | CISPLATIN + FLUOROURACIL | 02 | N | 300017894 | CISPLATIN + FLUOROURACIL |
| 300004088 | 300002867 | 1.63 | 55.3 | Curative (C) | 2016-06-09 | 2016-06-09 | Capecitabine | N | Y | 300017897 | CAPECITABINE |
| 300004089 | 300002868 | 1.73 | 83.3 | Not known (9) | 2016-02-01 | 2016-02-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300017899 | CARBOPLATIN + PACLITAXEL |
| 300004090 | 300002868 | 0 | 61 | null | null | 2017-10-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017899 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004091 | 300002869 | 1.62 | 66.2 | Adjuvant (A) | 2017-02-16 | 2017-02-24 | Capecitabine | N | N | 300017903 | CAPECITABINE |
| 300004092 | 300006058 | 1.7 | 67.7 | Neo-adjuvant (N) | 2014-05-14 | 2014-06-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017904 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004093 | 300002870 | 1.65 | null | null | null | 2013-08-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017908 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004094 | 300002871 | 2 | 73.5 | Curative (C) | 2018-06-01 | 2018-06-05 | Cetuximab 7 day (Cycle 1) | 02 | N | 300017909 | CETUXIMAB |
| 300004095 | 300006059 | 1.6 | 73.4 | Neo-adjuvant (N) | null | 2017-03-24 | Cisplatin +Fluorouracil (2 wk) | Y | null | 300017913 | CISPLATIN + FLUOROURACIL |
| 300004096 | 300002872 | 1.7 | 63 | Neo-adjuvant (N) | 2016-10-18 | 2016-10-30 | CISPLATIN + FLUOROURACIL | 2 | N | 300017916 | CISPLATIN + FLUOROURACIL |
| 300004097 | 300002872 | 1.83 | 83 | Neo-adjuvant (N) | 2017-06-29 | 2017-07-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017916 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004098 | 300002873 | 1.6 | 43.15 | Curative (C) | 2015-01-13 | 2015-01-22 | CETUXIMAB | 02 | Y | 300017922 | CETUXIMAB |
| 300004099 | 300002874 | 1.45 | null | Neo-adjuvant (N) | 2016-03-13 | 2016-03-13 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300017928 | CARBOPLATIN + PACLITAXEL |
| 300004100 | 300002875 | 1.83 | 58.3 | Curative (C) | 2013-09-20 | 2013-09-20 | CETUXIMAB + RT | N | Y | 300017929 | CETUXIMAB + RT |
| 300004101 | 300002875 | 1.68 | 57.1 | Not known (9) | 2015-06-16 | 2015-07-07 | CISPLATIN + FLUOROURACIL | 02 | N | 300017929 | CISPLATIN + FLUOROURACIL |
| 300004102 | 300002876 | 1.57 | 69.1 | Neo-adjuvant (N) | 2014-10-16 | 2014-10-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017931 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004103 | 300002877 | 1.55 | null | Curative (C) | 2015-10-14 | 2015-10-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300017933 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004105 | 300002879 | 1.72 | 86 | null | 2015-04-09 | 2015-04-25 | CISPLATIN + FLUOROURACIL | N | Y | 300017940 | CISPLATIN + FLUOROURACIL |
| 300004106 | 300002880 | 1.64 | 105.8 | Neo-adjuvant (N) | 2017-01-27 | 2017-01-27 | CISPLATIN + FLUOROURACIL | 2 | null | 300017943 | CISPLATIN + FLUOROURACIL |
| 300004107 | 300002880 | 1.82 | 62.8 | Neo-adjuvant (N) | 2015-07-07 | 2015-07-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300017943 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004108 | 300002881 | null | 64 | Neo-adjuvant (N) | 2017-07-18 | 2017-07-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300017954 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004109 | 300002881 | 1.8 | 81.2 | Neo-adjuvant (N) | 2016-08-08 | 2016-10-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017954 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004110 | 300002882 | null | 79.6 | Adjuvant (A) | 2016-03-16 | 2016-04-11 | Trial Unspecified | 02 | N | 300017959 | TRIAL |
| 300004112 | 300002884 | 1.6 | 63 | Neo-adjuvant (N) | 2017-11-14 | 2017-11-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300017973 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004113 | 300002885 | null | 77.2 | Adjuvant (A) | 2014-06-17 | 2014-07-07 | CETUXIMAB | 02 | Y | 300017979 | CETUXIMAB |
| 300004114 | 300002885 | 1.51 | 72 | Palliative (P) | null | 2017-08-03 | CISPLATIN + FLUOROURACIL | N | N | 300017979 | CISPLATIN + FLUOROURACIL |
| 300004115 | 300002886 | 1.58 | 63.9 | Adjuvant (A) | 2015-05-23 | 2015-05-28 | Capecitabine | 02 | N | 300017986 | CAPECITABINE |
| 300004116 | 300002886 | null | 60 | Neo-adjuvant (N) | 2013-07-01 | 2013-07-13 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300017986 | CISPLATIN + DOCETAXEL + FLUOROURACIL |